91 – 100 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus - An international inception cohort study
(
- Contribution to journal › Article
-
Mark
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
(
- Contribution to journal › Article
- 2006
-
Mark
Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations
(
- Contribution to journal › Article
-
Mark
The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab
(
- Contribution to journal › Article
-
Mark
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Mortality in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model
(
- Contribution to journal › Article
-
Mark
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.
(
- Contribution to journal › Article